國家衛生研究院 NHRI:Item 3990099045/11707
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 856851      線上人數 : 941
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/11707


    題名: Expression of FLJ10540, a novel oncogene, is associated with liver carcinogenesis and tumor progression through the activation of PKB/AKT pathway
    作者: Chen, CH;Huang, CYF;Lu, PJ;Chen, YC;Chou, CK
    貢獻者: National Institute of Cancer Research
    摘要: The explosion of microarray study has promised to shed light on the identification of potential disease markers and drug targets. A significant challenge is how to prioritize those differentially expressed and uncharacterized novel genes in tumor tissues. One such category is cell cycle regulated genes that are only evolved in higher organisms but not in lower eukaryotic cells. Characterization of these genes may reveal some novel human cancer specific abnormalities. Of the novel targets identified, FLJ10540 is overexpressed in human hepatocellular carcinoma (HCC) as examined by quantitative RT-PCR and immuno-histochemistry. FLJ10540 is highly expressed in various adult normal tissues including the placenta, thymus, ovary, small intestine and pancreas, but not in normal liver. By using overexpression of FLJ10540 or knock down with FLJ10540 siRNA approaches, we conclude that FLJ10540 displays several characteristics of oncogene, including enhance cell growth at low serum levels, confer drug resistance, exhibit anchorage-independent growth, and induce rapid tumorigenesis in nude mice. Finally, FLJ10540 overexpression stimulates phosphatidylinositol (PI) 3-kinase activity, leading to increased phosphorylation levels of Akt and its downstream targets. FLJ10540-elicited cell transformation can be inhibited by a PI3-kinase inhibitor (Wortmannin). Taken together, these results strongly suggest that FLJ10540 is a potential novel oncogene that may play a role in the carcinogenesis of human cancer cells.
    日期: 2006-04
    關聯: Cancer Research. 2006 Apr;66(8, Suppl.):610.
    Link to: http://cancerres.aacrjournals.org/content/66/8_Supplement/610.4
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0008-5472&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000454606200560
    顯示於類別:[黃奇英(2005-2007)] 會議論文/會議摘要

    文件中的檔案:

    沒有與此文件相關的檔案.



    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋